VERTEX PHARMACEUTICALS INC / MA (VRTX) Technical Analysis

🔺 Technical Setup

🎯 Decision Map

Pattern note: compression remains elevated around 73%, which means breakout quality matters more than noise inside the pattern.

📊 Technical Summary

VERTEX PHARMACEUTICALS INC / MA (VRTX) closed at 427.38 (+0.98%). Price remains below both the 50-day and 200-day moving averages, which keeps the broader technical backdrop under pressure until stronger recovery signals appear. 20-day momentum is running at -4.44%; price remains inside its roughly 52-week range (366.54–509.50); and ATR14 volatility is running near 2.09% of price. RSI(14) stands around 40.7, which keeps the momentum picture broadly balanced. RSI has been trending higher in recent sessions, indicating improving momentum conditions. MACD is positioned under the signal line, suggesting momentum recovery has not fully developed yet. The MACD histogram remains negative, suggesting momentum is still on the softer side. The chart is currently flagging Double top. On the upside, 446.86 is the nearest resistance area. A cleaner push through that zone would improve continuation potential. Latest fundamentals snapshot: Revenue: 3.08B · Net income: 1.08B · EPS (basic): 4.24. The interactive view adds overlays, pattern context and broader chart structure for deeper review.

Explore more